COVID-19 Outbreak-Global Fish Vaccine Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 123
The Fish Vaccine market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this....
COVID-19 Outbreak-Global Rituxan (rituximab) Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 104
Rituximab is a biologic medication for the treatment of autoimmune conditions and certain types of cancer. The drug refers to B-cells inhibitors class of medication, that are used in case....
COVID-19 Outbreak-Global Moxifloxacin Hcl (Cas 186826-86-8) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 130
The Moxifloxacin Hcl (Cas 186826-86-8) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak....
COVID-19 Outbreak-Global Allergy Rhinitis Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 104
Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. The Allergy Rhinitis Drugs....
COVID-19 Outbreak-Global Human Growth Hormones Deficiency (GHD) Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Jul 2020 | Page 120
The Human Growth Hormones Deficiency (GHD) Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under....